|
Volumn 55, Issue 11, 1998, Pages 1396-1398
|
New treatments in Alzheimer disease and the continued need for placebo- controlled trials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA TOCOPHEROL;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CHOLINESTERASE INHIBITOR;
DONEPEZIL;
GALANTAMINE;
METRIFONATE;
PHYSOSTIGMINE SALICYLATE;
SELEGILINE;
TACRINE;
ALZHEIMER DISEASE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
EDITORIAL;
HUMAN;
PRIORITY JOURNAL;
|
EID: 0031728926
PISSN: 00039942
EISSN: None
Source Type: Journal
DOI: 10.1001/archneur.55.11.1396 Document Type: Editorial |
Times cited : (10)
|
References (10)
|